Biological activity of recombinant human interleukin-2 produced in Escherichia coli
- PMID: 6367046
- DOI: 10.1126/science.6367046
Biological activity of recombinant human interleukin-2 produced in Escherichia coli
Abstract
The gene for interleukin-2 was isolated from the Jurkat cell line and from normal peripheral blood lymphocytes and, when inserted in Escherichia coli, was expressed at high concentrations. This interleukin-2 was purified to apparent homogeneity and tested for biological activity in a variety of assays in vitro and in vivo. The recombinant lymphokine supports the growth of murine and human interleukin-2 dependent cell lines, enhances the generation of murine and human cytolytic cells in vitro, and generates lymphokine activated killer cells from murine and human lymphocytes. It has a serum half-life of 2 to 3 minutes in the mouse and significantly enhances the generation of cytolytic cells in vivo after alloimmunization. No functional differences between native and the recombinant interleukin-2 molecules have been detected.
Similar articles
-
Comparison of the biological properties of purified natural and recombinant human interleukin-2.Biochem Biophys Res Commun. 1985 Apr 16;128(1):257-64. doi: 10.1016/0006-291x(85)91672-9. Biochem Biophys Res Commun. 1985. PMID: 3872661
-
Comparison of the biological activities of human recombinant interleukin-2(125) and native interleukin-2.J Biol Response Mod. 1985 Feb;4(1):96-109. J Biol Response Mod. 1985. PMID: 3920358
-
The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: direct correlation between reduction of established metastases and cytolytic activity of lymphokine-activated killer cells.J Immunol. 1986 May 15;136(10):3899-909. J Immunol. 1986. PMID: 2871106
-
Expression of murine interleukin-2 cDNA in E. coli and biological activities of recombinant murine interleukin-2.J Biochem. 1987 Oct;102(4):715-24. doi: 10.1093/oxfordjournals.jbchem.a122109. J Biochem. 1987. PMID: 3325499
-
Interleukin-2 and lymphokine activated killer cells: promises and cautions.Ann Clin Lab Sci. 1989 Jan-Feb;19(1):51-5. Ann Clin Lab Sci. 1989. PMID: 2644890 Review.
Cited by
-
Treatment of hepatocellular carcinoma utilizing lymphokine-activated killer cells and interleukin-2.Cancer Chemother Pharmacol. 1989;23 Suppl:S45-8. doi: 10.1007/BF00647239. Cancer Chemother Pharmacol. 1989. PMID: 2538266
-
Apparent interleukin 2 (IL-2) inhibitory activity of human serum is due to rapid killing of IL-2-dependent mouse cells.Clin Exp Immunol. 1987 Sep;69(3):624-31. Clin Exp Immunol. 1987. PMID: 3117461 Free PMC article.
-
Anti-IL-2 receptor monoclonal antibody AMT-13 increases soluble IL-2 receptor levels in vivo.Immunology. 1989 Feb;66(2):183-9. Immunology. 1989. PMID: 2647626 Free PMC article.
-
Three schedules of recombinant human interleukin-2 in the treatment of malignancy: side effects and immunologic effects in relation to serum level.Jpn J Cancer Res. 1988 Jan;79(1):131-43. doi: 10.1111/j.1349-7006.1988.tb00020.x. Jpn J Cancer Res. 1988. PMID: 3128501 Free PMC article.
-
Recombinant murine GM-CSF from E. coli has biological activity and is neutralized by a specific antiserum.EMBO J. 1985 Oct;4(10):2575-81. doi: 10.1002/j.1460-2075.1985.tb03973.x. EMBO J. 1985. PMID: 3902470 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources